Ingrid Maes is an experienced professional in the fields of management consultancy, investment, and business strategy, currently serving as an Investment Committee Member for the Flanders Future Tech Fund at PMV since January 2023. As Managing Director and Founder of Inovigate since September 2013, Ingrid leads an independent consultancy specializing in the European Pharmaceutical, Life Science, Medical Device, and Healthcare sectors, focusing on guiding clients through complex financial and strategic challenges. Previous roles include Program Director at MBI Life Sciences & Health, Director of Pharma & Life Science Strategy Consulting at PricewaterhouseCoopers, and Independent Consultant at IM C&C. Ingrid has contributed to various organizations, such as the King Baudouin Foundation and Vlerick Business School, and co-founded H2M - Health to Market. Ingrid holds a Master's degree in Engineering Sciences from Vrije Universiteit Brussel and a degree from the Institute for Pharmaceutical Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices